The decline patterns of neutralizing antibodies following coronavirus disease 2019 (COVID-19) vaccination.
BioAegis scores $20m BARDA contract to develop ARDS therapy – Pharmaceutical Technology
ARDS causes a fluid build-up in the lungs resulting from a severe complication of pneumonia, sepsis, Covid-19, or trauma. Image Credit: Design_Cells / Shutterstock. The